Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 25-Mar-2022 titled Sun Pharma Presents Phase 3 Data for WINLEVI�� (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting
Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 25-Mar-2022 titled Sun Pharma Presents Phase 3 Data for WINLEVI�� (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting